Quit Because of COVID–19 Act

H.R. 2185, the Quit Because of COVID-19 Act S. 1314/H.R. 2786, Tobacco Tax Equity Act S. 2043/H.R. 3883, To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes. FDA action on menthol cigarettes and other menthol tobacco products Synthetic nicotine

Client expense: $600,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying Report: April 1 - June 30, 2022 (Action Fund) Federal (under tobacco issue code) Legislation: H.R. 8239 House FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 8295 House FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) Senate FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and regulation of tobacco products) Senate FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) H.R. 2125/H.R. 2185 Quit Because of COVID-19 Act H.R. 7585 Health Equity and Accountability Act Issues FDA action to address synthetic nicotine FDA premarket review of e-cigarettes FDAs proposed rules on menthol cigarettes and flavored cigars Medicaid and tobacco cessation Reducing nicotine levels in cigarettes Tobacco cessation in general Tobaccos role in health disparities

Client expense: $340,000 · Firm income: Not reported

Legislation and policies related to: Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices H.R. 2185/S. 2622, Quit Because of COVID-19 Act H.R. 2786/S. 1314, Tobacco Tax Equity Act of 2021 H.R. 6286, Clarifying Authority of Nicotine Act of 2021

Client expense: Not reported · Firm income: $24,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2185/S.2622 - Quit Because of COVID-19 Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying Report: April 1 - June 30, 2022 (Action Fund) Federal (under tobacco issue code) Legislation: H.R. 8239 House FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 8295 House FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) Senate FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and regulation of tobacco products) Senate FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) H.R. 2125/H.R. 2185 Quit Because of COVID-19 Act H.R. 7585 Health Equity and Accountability Act Issues FDA action to address synthetic nicotine FDA premarket review of e-cigarettes FDAs proposed rules on menthol cigarettes and flavored cigars Medicaid and tobacco cessation Reducing nicotine levels in cigarettes Tobacco cessation in general Tobaccos role in health disparities

Client expense: $340,000 · Firm income: Not reported

H.R. 2185, the Quit Because of COVID-19 Act S. 1314/H.R. 2786, Tobacco Tax Equity Act S. 2043/H.R. 3883, To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes. FDA action on menthol cigarettes and other menthol tobacco products Synthetic nicotine

Client expense: $470,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act

Client expense: Not reported · Firm income: $80,000

Legislation and policies related to: Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices H.R. 2185/S. 2622, Quit Because of COVID-19 Act H.R. 2786/S. 1314, Tobacco Tax Equity Act of 2021 H.R. 6286, Clarifying Authority of Nicotine Act of 2021

Client expense: Not reported · Firm income: $24,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2185/S.2622 - Quit Because of COVID-19 Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2185, the Quit Because of COVID-19 Act S. 1314/H.R. 2786, Tobacco Tax Equity Act S. 2043/H.R. 3883, To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes. FDA action on menthol cigarettes and other menthol tobacco products Synthetic nicotine

Client expense: $570,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation and policies related to: Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices H.R. 2185/S. 2622, Quit Because of COVID-19 Act H.R. 2786/S. 1314, Tobacco Tax Equity Act of 2021

Client expense: Not reported · Firm income: $24,000

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)

Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act H.R. 5546/S. 2974, the PROTECT Act H.R. 6286, the Clarifying Authority over Nicotine Act of 2021

Client expense: $580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2185, the Quit Because of COVID-19 Act S. 1314/H.R. 2786, Tobacco Tax Equity Act S. 2043/H.R. 3883, To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes. FDA action on menthol cigarettes and other menthol tobacco products

Client expense: $570,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

The Quit Because of COVID-19 Act (H.R. 2185/S. 2622).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and policies related to: Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices H.R. 2185/S. 2622, Quit Because of COVID-19 Act H.R. 2786/S. 1314, Tobacco Tax Equity Act of 2021

Client expense: Not reported · Firm income: $24,000

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)

The Quit Because of COVID-19 Act (H.R. 2185/S. 2622).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 2185, the Quit Because of COVID-19 Act S. 1314/H.R. 2786, Tobacco Tax Equity Act S. 2043/H.R. 3883, To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes. FDA action on menthol cigarettes and other menthol tobacco products

Client expense: $580,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

S.674 - Public Health Infrastructure Saves Lives Act; Strengthening public health infrastructure, workforce and data in preparation for the next pandemic; H.R. 2185/S. 2622 - Quit Because of COVID-19 Act; H.R. 2786/S. 1314 - Tobacco Tax Equity Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)

 S. 916/H.R. 1897, MOMMAS Act; provisions related to the taxation of tobacco products H.R. 2185, Quit Because of COVID-19 Act S. 984/H.R. 2238, Break Free from Plastic Pollution Act; provisions related to plastic pollution from consumer products from getting into animal & human food-chains, landscapes, and waterways across the United States and into oceans S.1314/H.R.2786, Tobacco Tax Equity Act of 2021 H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act H.R. 3066, Guam Cigarette Tax Enforcement Act H.R. 3326, Accurate Reporting of Smoking Variants Act of 2020 H.R.3684 - INVEST in America Act; provisions related to the prohibition of cigarettes and e-cigarettes on Amtrak trains S. 2044/H.R. 3865, Children Dont Belong on Tobacco Farms Act S. 2106/H.R. 3700, Prohibit Smoking at VA Facilities Act 116th Congress H.R. 293, Youth Vaping Prevention Act S. 655/H.R. 1498, SAFE Kids Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act H.R. 4742, Imposition of Tax on Nicotine for Use in Vapor Act S. 2463, E-Cigarette Tax Parity Act S. 1253/H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act S. 2519, Ending New Nicotine Dependencies (ENND) Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA PMTA and MRTP compliance policies Issues surrounding taxation of tobacco products Issues surrounding efforts to prevent youth access to tobacco products January 2020 FDA guidance on flavors in vapor products Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act January 2020 FDA guidance on flavors in vapor products FDA proposed rule concerning NNN Levels in Smokeless Tobacco Products ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001

The Quit Because of COVID-19 Act (H.R. 2185).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2185, the Quit Because of COVID-19 Act S. 1314/H.R. 2786, Tobacco Tax Equity Act S. 2043/H.R. 3883, To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes. FDA action on menthol cigarettes and other menthol tobacco products

Client expense: $500,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

  S. 916/H.R. 1897, MOMMAS Act; provisions related to the taxation of tobacco products H.R. 2185, Quit Because of COVID-19 Act 116th Congress H.R. 293, Youth Vaping Prevention Act S. 655/H.R. 1498, SAFE Kids Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act H.R. 4624, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act H.R. 4742, Imposition of Tax on Nicotine for Use in Vapor Act S. 2463, E-Cigarette Tax Parity Act S. 1253/H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act S. 2519, Ending New Nicotine Dependencies (ENND) Act S. 3263/H.R. 5845, Break Free from Plastic Pollution Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA PMTA and MRTP compliance policies Issues surrounding taxation of tobacco products Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products January 2020 FDA guidance on flavors in vapor products FDA proposed rule concerning NNN Levels in Smokeless Tobacco Products ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001

Client expense: $490,000 · Firm income: Not reported

The Quit Because of COVID-19 Act (H.R. 2185).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office